Duodenal ulceration, gastric ulceration

Indication for Cimetidine

Population group: Suitable for both men and women, only adults (18 years old or older)

Cimetidine is indicated in the treatment of duodenal and benign gastric ulceration.

For this indication, competent medicine agencies globally authorize below treatments:

800-1,600 mg in 2-4 divided doses daily

Route of admnistration

Oral

Defined daily dose

800 - 1,600 mg

Dosage regimen

From 200 To 400 mg 4 time(s) per day every day

Detailed description

The usual dosage is 400mg twice a day, with breakfast and at bedtime. For patients with duodenal or benign gastric ulceration, a single daily dose of 800mg at bedtime is recommended. Other effective regimens are 200mg three times a day with meals and 400mg at bedtime (1.0g/day) and, if inadequate, 400mg four times a day (1.6g/day), also with meals and at bedtime.

Treatment may be continued for longer periods in those patients who may benefit from reduction of gastric secretion and the dosage may be reduced as appropriate to 400mg at bedtime or 400mg in the morning and at bedtime. In patients with benign peptic ulcer disease who have responded to the initial course, relapse may be prevented by continued treatment, usually with 400mg at bedtime; 400mg in the morning and at bedtime has also been used.

Active ingredient

Cimetidine is a histamine H2-receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. It is a reversible, competitive antagonist, and is used as an anti-ulcer drug.

Read more about Cimetidine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner